top of page

New report on Living with an Inflammatory Neuropathy

When we talk about Inflammatory Neuropathies, it’s easy

for conversations to become focused on diagnoses, treatments, or clinical pathways. But behind every statistic is a person trying to get through the day while managing fatigue, pain, mobility issues, uncertainty, and often a feeling that they are doing it alone.

That is exactly why the latest My Neuro Survey mattered so much.


The survey is the largest patient experience survey for neurological conditions in the UK, with more than 10,000 responses from people directly impacted and those supporting them. For us at Inflammatory Neuropathies UK, it gave something incredibly valuable. Real evidence from real people about what life is actually like living with Guillain Barré Syndrome, CIDP, and other Inflammatory Neuropathies.

As a charity, we pushed hard to make sure our community took part because we believe decisions should be shaped by lived experience, not assumptions. The response from our community was incredible. Inflammatory Neuropathies UK was the sixth highest contributing organisation out of 64 charities and organisations involved in the survey.


That matters because when more people speak up, it becomes much harder for systems to ignore what is happening. While the survey was undertaken a while back, we wanted to delve into the data a bit more, and find out what it really means for our Community.


What came through most strongly in the findings was the scale of impact these conditions have on everyday life. People talked about fatigue, pain, mobility problems, sleep issues, cognitive difficulties, work pressures, and the emotional toll of trying to navigate life while feeling unsupported.

None of that will surprise many people in our community. But seeing it evidenced across such a large set of data is powerful.


One of the biggest themes was that people often feel under supported by the healthcare system. Many respondents said they did not always feel supported after diagnosis or discharge from hospital, and some people reported receiving little or no information about their condition at all.


That should concern all of us. Nobody should leave hospital after a life changing condition feeling abandoned or unsure where to turn next. Yet we hear this time and time again through our own support services, and now we can clearly see it reflected in national data as well.


The findings around work and employment also stood out. Many people said their condition impacted their ability to work or study, while some had stopped working completely.


For many people impacted by Inflammatory Neuropathies, recovery or management is not straightforward. Symptoms can fluctuate. Energy levels can disappear without warning. Pain and fatigue are often invisible to other people. Trying to balance that with employment, finances, and family life can become overwhelming very quickly.


Another important finding was around research, especially in terms of clinical trials. People want to be involved. Across all patient groups, most respondents said they would take part in clinical research, yet very few had actually been given the opportunity.


For me, that highlights both a challenge and an opportunity. As a sector, we need to do far better at connecting people with research opportunities, clinical trials, and innovation. People impacted by these conditions do not just want support, they want progress, they want to help shape the future.

The report also highlighted something that we as a charity need to reflect on honestly. We are reaching people and making a difference, but we are still not reaching enough of the community.


That is one of the biggest reasons we wanted this data. Good charities should not be afraid of evidence. We should actively seek it out, even when it challenges us. Data like this helps us understand where gaps exist, where inequalities remain, and where we need to improve.


At Inflammatory Neuropathies UK, we are already using these findings to shape our future work. That includes improving information, strengthening support after diagnosis and discharge, increasing awareness amongst healthcare professionals, improving access to research opportunities, and making sure we engage with more people impacted by these conditions.


Most importantly, this report reinforces something we have always believed. People impacted by Inflammatory Neuropathies deserve better visibility, better support, better information, and better opportunities. Their experiences matter, and their voices should shape what happens next.


This report is not just about identifying problems, it is about making sure people are heard. Then we need to turn these insights into action.


That is exactly what we intend to do.

 

You can read the full report at inflammatoryneuropathies.uk/reports

bottom of page